Aspen Aerogels Inc: Form 10-K/A for the period ended Dec 31, 2025
Filed with the SEC on Mar 23, 2026 and accepted by EDGAR at Mar 23, 2026, 16:48 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $271.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $225.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $46.0m | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $13.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$378.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $2.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$389.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$4.73 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$4.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 82,328,484 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $32.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $37.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-12-31 | $156.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $242.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $406.7m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $62.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $171.2m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $65.5m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-12-31 | $25.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $235.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-119892. Last ingested by Listed: Nov 6, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.